Analysis of p16 gene deletion and point mutation in breast carcinoma.
暂无分享,去创建一个
B. Quesnel | J. Bonneterre | J. Peyrat | C. Preudhomme | P. Fenaux | N. Philippe | J. Fournier | J. Peyrat | P. Fenaux | Claude Preudhomme | Jacques Bonneterre | Nathalie Philippe | Bruno Quesnel
[1] B. Quesnel,et al. p16 gene homozygous deletions in acute lymphoblastic leukemia. , 1995, Blood.
[2] A. Okamoto,et al. Mutations and altered expression of p16INK4 in human cancer. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[3] D. Louis,et al. Mutational analysis of CDKN2 (MTS1/p16ink4) in human breast carcinomas. , 1994, Cancer research.
[4] R. Hruban,et al. Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma , 1994, Nature Genetics.
[5] W. Clark,et al. Germline p16 mutations in familial melanoma , 1994, Nature Genetics.
[6] Peter A. Jones,et al. P16 gene in uncultured tumours , 1994, Nature.
[7] S. Mori,et al. Frequent somatic mutation of the MTS1/CDK4I (multiple tumor suppressor/cyclin-dependent kinase 4 inhibitor) gene in esophageal squamous cell carcinoma. , 1994, Cancer research.
[8] J. Pines. p21 inhibits cyclin shock , 1994, Nature.
[9] D. Carson,et al. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers , 1994, Nature.
[10] M. Skolnick,et al. A cell cycle regulator potentially involved in genesis of many tumor types. , 1994, Science.
[11] G. Hannon,et al. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4 , 1993, Nature.
[12] J. Sambrook,et al. Molecular Cloning: A Laboratory Manual , 2001 .